Y-Intercept (Hong Kong) Ltd

Position in ADMA — Adma Biologics, Inc.

CIK 1772875 HONG KONG, K3

Position in ADMA

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$4,800,872

-$4,888,680 QoQ

Shares Held

573,581

-46.7% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#51

of 321 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. ADMA ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	101,908	$10,865,430
2	MRNA	Moderna, Inc.	139,861	$9,794,465
3	BBIO	BridgeBio Pharma, Inc.	107,419	$8,000,567
4	AXSM	Axsome Therapeutics, Inc.	22,923	$5,610,862
5	IONS	Ionis Pharmaceuticals Inc	67,374	$5,342,084
6	ADMA	Adma Biologics, Inc. This page	573,581	$4,800,872
7	UPB	Upstream Bio, Inc.	693,555	$4,799,400
8	NRIX	Nurix Therapeutics, Inc.	192,434	$4,668,448

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,800,872	573,581	-46.7%	Shares	Sole	2026-07-14
2026-03-31	$9,689,552	1,075,422	+1508.1%	Shares	Sole	2026-04-27
2025-12-31	$1,219,781	66,874	-36.5%	Shares	Sole	2026-02-13
2025-09-30	$1,543,448	105,283	+40.6%	Shares	Sole	2025-10-31
2025-06-30	$1,363,765	74,891	+107.6%	Shares	Sole	2025-08-01
2025-03-31	$715,866	36,082	+21.3%	Shares	Sole	2025-05-06
2024-12-31	$510,195	29,749	-12.6%	Shares	Sole	2025-02-04
2024-06-30	$380,734	34,055	+77.3%	Shares	Sole	2024-08-14
2023-06-30	$70,862	19,204	-60.3%	Shares	Sole	2023-08-14
2022-03-31	$88,440	48,328	+190.2%	Shares	Sole	2022-05-16
2021-06-30	$26,649	16,656	—	Shares	Sole	2021-08-26
No filing history on record for this holder in this stock.